Literature DB >> 9311791

Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase.

K E Reed1, J Xu, C M Rice.   

Abstract

NS5A derived from a hepatitis C virus (HCV) genotype 1b isolate has previously been shown to undergo phosphorylation on serine residues (T. Kaneko, Y. Tanji, S. Satoh, M. Hijikata, S. Asabe, K. Kimura, and K. Shimotohno, Biochem. Biophys. Res. Commun. 205:320-326, 1994). In this report, phosphorylation of NS5A derived from HCV isolates of the 1a and distantly related 2a genotypes is demonstrated. Phosphoamino acid analysis of NS5A from the 1a isolate indicated that phosphorylation occurs predominantly on serine, with a minor fraction of threonine residues also being phosphorylated. NS5A phosphorylation was observed in diverse cell types, including COS-1, BHK-21, HeLa, and the hepatoma cell line HuH-7. Phosphorylation of a glutathione S-transferase (GST)/HCV-H NS5A fusion protein was also demonstrated in an in vitro kinase assay. This activity seemed to be highest when the pH of the reaction was neutral or slightly alkaline and displayed a preference for Mn2+ over Mg2+, with an optimum concentration of approximately 10 mM Mn2+. Somewhat surprisingly, in vitro phosphorylation of NS5A was inhibited by the addition of > or = 0.25 mM Ca2+ to reaction buffer containing Mn2+ and/or Mg2+. Comparison of phosphopeptide maps of NS5A phosphorylated in vitro and in cultured cells showed that most of the phosphopeptides comigrated, suggesting that one or more kinases involved in NS5A phosphorylation in vivo and in vitro are the same. The effects of various kinase inhibitors on NS5A phosphorylation were consistent with a kinase activity belonging to the CMGC group of serine-threonine kinases. The development of an in vitro kinase assay for NS5A phosphorylation should facilitate identification of kinase(s) responsible for its phosphorylation and of phosphorylation sites which may influence the function of NS5A in HCV propagation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311791      PMCID: PMC192058          DOI: 10.1128/JVI.71.10.7187-7197.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.

Authors:  A A Kolykhalov; E V Agapov; K J Blight; K Mihalik; S M Feinstone; C M Rice
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

2.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Photosensitized inhibition of growth factor-regulated protein kinases by hypericin.

Authors:  P Agostinis; A Vandenbogaerde; A Donella-Deana; L A Pinna; K T Lee; J Goris; W Merlevede; J R Vandenheede; P De Witte
Journal:  Biochem Pharmacol       Date:  1995-05-26       Impact factor: 5.858

4.  Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.

Authors:  T Chijiwa; A Mishima; M Hagiwara; M Sano; K Hayashi; T Inoue; K Naito; T Toshioka; H Hidaka
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

5.  Phosphorylation of Sindbis virus nsP3 in vivo and in vitro.

Authors:  G P Li; M W La Starza; W R Hardy; J H Strauss; C M Rice
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

6.  Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome.

Authors:  T Kaneko; Y Tanji; S Satoh; M Hijikata; S Asabe; K Kimura; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1994-11-30       Impact factor: 3.575

7.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

8.  Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A.

Authors:  Y Tanji; T Kaneko; S Satoh; K Shimotohno
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole of specific RNA polymerase II transcription.

Authors:  R Zandomeni; M C Zandomeni; D Shugar; R Weinmann
Journal:  J Biol Chem       Date:  1986-03-05       Impact factor: 5.157

10.  Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.

Authors:  M Inagaki; S Kawamoto; H Itoh; M Saitoh; M Hagiwara; J Takahashi; H Hidaka
Journal:  Mol Pharmacol       Date:  1986-06       Impact factor: 4.436

View more
  54 in total

1.  Phylogenetic and structural analysis of HCV nonstructural protein 4A from Pakistani patients.

Authors:  Najam us Sahar Sadaf Zaidi; Naghmana Kanwal; Awaisa Ghazal; Kaneez Fatima; Farakh Javed; Ishtiaq Qadri
Journal:  Virus Genes       Date:  2011-09-24       Impact factor: 2.332

2.  Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.

Authors:  J Nousbaum; S J Polyak; S C Ray; D G Sullivan; A M Larson; R L Carithers; D R Gretch
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 3.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

Review 4.  Regulatory mechanisms of viral hepatitis B and C.

Authors:  G Waris; A Siddiqui
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

5.  Modulation of hepatitis C virus genome encapsidation by nonstructural protein 4B.

Authors:  Qingxia Han; David Manna; Kerry Belton; Richard Cole; Kouacou V Konan
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

6.  Activity-based protein profiling of the hepatitis C virus replication in Huh-7 hepatoma cells using a non-directed active site probe.

Authors:  Ragunath Singaravelu; David R Blais; Craig S McKay; John Paul Pezacki
Journal:  Proteome Sci       Date:  2010-02-04       Impact factor: 2.480

Review 7.  Structure and functions of hepatitis C virus proteins: 15 years after.

Authors:  L Krekulová; V Rehák; L W Riley
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

8.  Protein-protein interactions between hepatitis C virus nonstructural proteins.

Authors:  Maria Dimitrova; Isabelle Imbert; Marie Paule Kieny; Catherine Schuster
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

9.  NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling.

Authors:  S L Tan; H Nakao; Y He; S Vijaysri; P Neddermann; B L Jacobs; B J Mayer; M G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 10.  Visualizing hepatitis C virus infection in humanized mice.

Authors:  Markus von Schaewen; Qiang Ding; Alexander Ploss
Journal:  J Immunol Methods       Date:  2014-03-15       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.